Eli Lilly and Company (LLY)

Drug Manufacturers - General · Healthcare · $1.07T

overvalued
Intrinsic Value (Consensus)
$475.68
Current Price
$1133.00
Margin of Safety
-58%
58% Above Intrinsic Value
Value: $476
Price: $1133

Valuation Model Estimates

Current Price: $1133.00
DCF (Discounted Cash Flow)
$745.22
Graham Number
$123.44
Earnings Power Value
$222.82
Relative Value (P/E)
$459.00
Dividend Discount Model
$2076.67
Consensus Value
$475.68

Model Assumptions

Discount Rate
10.3%
Growth Rate
20.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%

Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.

Key Financials

EPS (TTM)
$22.95
EPS (Forward)
$27.54
Book Value
$29.51
P/E Ratio
50.0
Forward P/E
41.7
PEG Ratio
ROE
77.8%
Debt/Equity
111%
Revenue Growth
44.7%
Earnings Growth
20.0%
Dividend Yield
0.5%
Beta
0.52

Data last updated: 2026-06-12

Source: Yahoo Finance